RSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine [Fortune]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Fortune
Neither is it uncommon among the youngest and oldest populations, infecting most babies and toddlers before their second birthday and accounting for the annual hospitalization of up to 160,000 U.S. adults 60 and older In recent years, however, COVID-19 has not only stolen the public health spotlight but also eclipsed the development of the first RSV vaccine. “[RSV] can be very risky, but people are not as aware of it as a virus in itself,” Dr. Sujata Ambardar , an infectious disease specialist at Inova Fairfax Hospital in Falls Church, Va., tells Fortune . “They think of COVID, flu, and other viruses.” Though Ambardar believes RSV awareness is on the rise, she says the existing lack of patient education—coupled with COVID- and flu-induced vaccine fatigue—may account for minimal interest in the trio of new RSV vaccines for people 60 and older. As recently as 18 months ago, no RSV vaccine existed. The Food and Drug Administration (FDA) approved the nation's first RSV vaccine, GS
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer Inc. (NYSE:PFE) is largely controlled by institutional shareholders who own 67% of the company [Yahoo! Finance]Yahoo! Finance
- As Tom Brady returns home, idol Joe Montana reveals traits that made him great [FOX News]FOX News
- Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.MarketBeat
- Enara Bio secures $32.5m for ‘Dark Antigen' cancer therapies [Yahoo! Finance]Yahoo! Finance
- Pfizer Inc. (PFE): A Low-Cost Stock with High Growth Potential [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 7/30/24 - Beat
PFE
Sec Filings
- 10/2/24 - Form 4
- 10/2/24 - Form 4
- 10/2/24 - Form 4
- PFE's page on the SEC website